Sustained virological response after treatment with direct-acting antivirals can help immune reconstitution in HIV-HCV coinfected patients even in case of persistent HIV low-level viremia
- PMID: 33364441
- PMCID: PMC7752158
- DOI: 10.1002/hsr2.221
Sustained virological response after treatment with direct-acting antivirals can help immune reconstitution in HIV-HCV coinfected patients even in case of persistent HIV low-level viremia
Conflict of interest statement
The authors declare no conflict of interest for this article.
References
-
- Parisi SG, Andreis S, Mengoli C, et al. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV‐DNA decrease during successful interferon‐free anti‐HCV therapy in HIV‐1‐HCV co‐infected patients on effective combined anti‐HIV treatment. Med Microbiol Immunol. 2018;207:183‐194. - PubMed
-
- López‐Cortés LF, Trujillo‐Rodríguez M, Báez‐Palomo A, et al. Eradication of hepatitis C virus (HCV) reduces immune activation, microbial translocation, and the HIV DNA level in HIV/HCV‐Coinfected patients. J Infect Dis. 2018;218:624‐632. - PubMed
-
- Corma‐Gómez A, Morano L, Téllez F, et al. HIV infection does not increase the risk of liver complications in hepatitis C virus‐infected patient with advanced fibrosis, after sustained virological response with direct‐acting antivirals. Aids. 2019;33:1167‐1174. - PubMed
-
- Sarmati L, Parisi SG, Nicastri E, et al. Cellular HIV‐1 DNA quantitation in patients during simplification therapy with protease inhibitor‐sparing regimens. J Med Virol. 2007;79:880‐886. - PubMed
LinkOut - more resources
Full Text Sources
